Cellular models for discovering prion disease therapeutics: Progress and challenges.

Krance, Saffire H; Luke, Russell; Shenouda, Marc; Israwi, Ahmad R; Colpitts, Sarah J; Darwish, Lina; Strauss, Maximilian; Watts, Joel C

Krance, Saffire H; Luke, Russell; Shenouda, Marc; Israwi, Ahmad R; Colpitts, Sarah J; Darwish, Lina; Strauss, Maximilian; Watts, Joel C.

Afiliação

Krance SH; Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada.
Luke R; Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, ON, Canada.
Shenouda M; Department of Cell and Systems Biology, University of Toronto, Toronto, ON, Canada.
Israwi AR; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
Colpitts SJ; Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON, Canada.
Darwish L; Department of Cell and Systems Biology, University of Toronto, Toronto, ON, Canada.
Strauss M; Department of Immunology, University of Toronto, Toronto, ON, Canada.
Watts JC; Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada.

J Neurochem ; 153(2): 150-172, 2020 04.

Article em En | MEDLINE | ID: mdl-31943194

Assuntos

Técnicas In Vitro/métodos; Doenças Priônicas; Príons; Animais; Células Cultivadas; Humanos; Príons/metabolismo

Palavras-chave

Creutzfeldt-Jakob disease; cultured cells; prion; therapies

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Técnicas In Vitro / Príons / Doenças Priônicas Limite: Animals / Humans Idioma: En Revista: J Neurochem Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google